Novo Nordisk
NVO
#19
Rank
$478.09 B
Marketcap
$105.32
Share price
-1.49%
Change (1 day)
6.17%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2024 : $18.05 Billion USD

According to Novo Nordisk's latest financial reports the company has $18.05 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$15.78 B31.27%
2022-12-31$$12.02 B11.62%
2021-12-31$$10.77 B2.9%
2020-12-31$$10.46 B21.22%
2019-12-31$$8.63 B8.72%
2018-12-31$$7.94 B-1.1%
2017-12-31$$8.03 B25.29%
2016-12-31$$6.40 B-6.88%
2015-12-31$$6.88 B4.59%
2014-12-31$$6.58 B-16.5%
2013-12-31$$7.88 B9.39%
2012-12-31$$7.20 B10.44%
2011-12-31$$6.52 B-1.11%
2010-12-31$$6.59 B-4.16%
2009-12-31$$6.88 B10.89%
2008-12-31$$6.20 B-1.56%
2007-12-31$$6.30 B18.04%
2006-12-31$$5.34 B22.28%
2005-12-31$$4.36 B-10.07%
2004-12-31$$4.85 B13.56%
2003-12-31$$4.27 B29.95%
2002-12-31$$3.29 B14.01%
2001-12-31$$2.88 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$92.55 B 412.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.32 B-20.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.20 B-4.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$78.25 B 333.42%๐Ÿ‡ซ๐Ÿ‡ท France